Abstracts tagged "Diagnosis and gout"

Abstract Number: 222 • 2016 ACR/ARHP Annual Meeting
Role of Synovial Biopsy in Diagnosis of Crystal Arthropathies
Viju Moses¹, Jaya Asirvatham², Jonathan McHugh² and Robert Ike¹, ¹Division of Rheumatology, University of Michigan, Ann Arbor, MI, ²Department of Pathology, University of Michigan, Ann Arbor, MI
Title: Role of Synovial Biopsy in Diagnosis of Crystal Arthropathies Background/Purpose: Diagnosis of crystal arthropathies (CAs) can be challenging. Advances in arthroscopy and ultrasound guided…
Abstract Number: 1199 • 2013 ACR/ARHP Annual Meeting
The Performance Of a Novel Scoring System In The Differential Diagnosis Between Acute Gout and Septic Arthritis
Jung-Soo Song¹, Kwang-Hoon Lee², Sang Tae Choi¹, Eun-Jin Kang³ and You-Jung Ha⁴, ¹Rheumatology, Chung-Ang University College of Medicine, Seoul, South Korea, ²Dongguk University Ilsan Hospital, Goyang, South Korea, ³Rheumatology, Busan Medical Center, Busan, South Korea, ⁴Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea
Background/Purpose: Recently, a novel scoring system was developed for the diagnosis of gout without joint fluid analysis (1). The performance of this scoring system in the…
Abstract Number: 1182 • 2013 ACR/ARHP Annual Meeting
The Performance Of a Diagnostic Rule For Acute Gouty Arthritis Without Joint Fluid Analysis: a Validation Study
Laura Kienhorst¹, Hein Janssens², Jaap Fransen³ and Matthijs Janssen¹, ¹Department of Rheumatology, Rijnstate Hospital, Arnhem, Netherlands, ²Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, ³Department of Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
Background/Purpose: The gold standard to diagnose gout is the identification of monosodium urate (MSU) crystals in joint fluid. In primary care gout is mostly diagnosed…
Abstract Number: 2412 • 2012 ACR/ARHP Annual Meeting
Valdiation of a Diagnosis of Gout in the Epiccare Electronic Medical Records
Neera Narang¹ and Eswar Krishnan², ¹Stanford Univ Medical Center, Stanford, CA, ²Medicine, Standford University, Palo Alto, CA
Background/Purpose: Electronic Medical Records (EMR) offer great opportunities for pharmacoepidemiologic, health outcome and health services research. However, the critical limiting factor in the widespread use of…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].